Diagnostic and Interventional Cardiology

Medical center signs agreement to acquire the Company’s digital signal processing technology for arrhythmia care

News | EP Device Monitoring Systems

BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP Technology

January 13, 2023 — BioSig Technologies, Inc., an advanced digital signal processing technology company delivering ...

January 13, 2023

ASNC releases comprehensive tool for assessing quality, setting meaningful goals, improving patient care in SPECT MPI laboratories

News | Cardiac Imaging

New Guide Will Change How Cardiac Imagers Approach Quality Improvement

January 13, 2023 — Nuclear stress testing performed with single-photon emission computed tomography (SPECT) is the most ...

January 13, 2023

Patients seen at transplant centers had almost 80% higher odds to receive “bridge-to-transplant” designation

News | Heart Failure

Medicare Policy Change Could Increase Inequity in Heart Transplant Access, Study Finds

January 13, 2023 — A change to Medicare policy surrounding heart transplant may lead to increased inequities in access ...

January 13, 2023

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions.

News | Drug-Eluting Balloons

MedAlliance Selution SLR is the First DEB to Receive Coronary de novo IDE Approval, its Fourth FDA IDE DEB Approval

January 12, 2023 — Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional FDA ...

January 12, 2023

ADVANCE Trial compares sac regression in the Medtronic Endurant II/IIs stent graft system and the Gore® Excluder AAA Device Family systems

News | Stent Grafts

Medtronic Announces First Enrollment in Head-to-head Global Randomized Trial Evaluating Durability of Endovascular Aneurysm Repair

January 12, 2023 — Medtronic announced the first patient enrollment in the ADVANCE Trial, a head-to-head randomized ...

January 12, 2023

Alameda, CA-based global healthcare company Penumbra has announced Food & Drug Administration (FDA) clearance and launch of Lightning Flash, which the company reports is the most advanced mechanical thrombectomy system on the market to address venous and pulmonary thrombus.

News | Cardiovascular Business

FDA Clearance and Launch Granted to Penumbra Mechanical Thrombectomy System

January 11, 2023 — The Alameda, Calif.-based global healthcare company Penumbra has announced U.S. Food & Drug ...

January 11, 2023

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

Phase 2 trials underway with ninerafaxstat in three cardiovascular indications; multiple data read-outs expected in 2023

News | Cardiovascular Clinical Studies

Imbria Enrolls First Patient in the Phase 2 IMPROVE-DiCE Clinical Trial Evaluating Ninerafaxstat in Patients with Heart Failure with Preserved Ejection Fraction

January 11, 2023 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies ...

January 11, 2023

News | Embolic Protection Devices

Shockwave Intravascular Lithotripsy-assisted TMVR Shows Promise for Patients with Severe Stenosis and Regurgitation

January 11, 2023 — In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved ...

January 11, 2023

A Rutgers analysis of U.S. stroke deaths from 1975 to 2019 has found both a dramatic decline and the potential for an important resurgence.

News | Stroke

After 40 Years of Decline, Stroke Death Rates Are Rising Again

January 11, 2023 — A Rutgers analysis of U.S. stroke deaths from 1975 to 2019 has found both a dramatic decline and the ...

January 11, 2023

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Organizations relying on multiple cardiovascular systems might find it difficult to onboard new facilities because disparate systems don’t easily communicate with each other.

Sponsored Content | Case Study | Information Technology

Single-Database Cardiology Platform Drives Efficient Workflow and Improves Data Access

This case study from Change Healthcare presents the following: Customer: Washington Health System Washington, PA ...

January 10, 2023

CinCor Pharma, Inc. announced that it has entered into a definitive agreement with AstraZeneca under which AstraZeneca has agreed to acquire CinCor.

News | Cardiovascular Business

CinCor Pharma to be Acquired by AstraZeneca

January 9, 2023 — CinCor Pharma, Inc. announced that it has entered into a definitive agreement with AstraZeneca under ...

January 09, 2023

News | Cardiovascular Business

ReCor Medical Names Lara Barghout President and Chief Executive Officer

January 9, 2023 — ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced the appointment ...

January 09, 2023

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

$TGCV is an emerging cardiovascular disorder characterized by diffuse narrowing coronary atherosclerosis with triglyceride (TG) deposition caused by defective intracellular lipolysis. TGCV is an often-undiagnosed condition in patients who are resistant to standard therapies. Panels A and B concern two patients in their 60s with refractory angina pectoris and diabetes mellitus. After being diagnosed with TGCV, they started dietary intake of tricaprin. Their symptoms improved within a couple of months. Follow-$